CCR2 and non-small cell lung carcinoma: Then, we detected a significant effect of LC on IgD on IgD+ B cell (OR: 0.850, 95% CI [0.725, 0.996], P=0.045), as well as NSCLC on CCR2 on CD14- CD16- Monocyte (OR: 0.900, 95% CI [0.825, 0.982], P=0.017) (Figure 4).